Clene Inc Stock Net Asset
| CLNN Stock | USD 3.88 0.20 4.90% |
Clene Inc fundamentals help investors to digest information that contributes to Clene's financial success or failures. It also enables traders to predict the movement of Clene Stock. The fundamental analysis module provides a way to measure Clene's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Clene stock.
Clene |
Clene Inc Company Net Asset Analysis
Clene's Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Current Clene Net Asset | 52.34 M |
Most of Clene's fundamental indicators, such as Net Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Clene Inc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Net Asset is the value used in calculating NAV of a fund. NAV (or Net Asset Value) is computed once a day based on the formula that uses closing prices of all positions in the fund's portfolio.
| Competition |
Based on the recorded statements, Clene Inc has a Net Asset of 52.34 M. This is much higher than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The net asset for all United States stocks is notably lower than that of the firm.
Clene Net Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Clene's direct or indirect competition against its Net Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Clene could also be used in its relative valuation, which is a method of valuing Clene by comparing valuation metrics of similar companies.Clene is currently under evaluation in net asset category among its peers.
Clene Fundamentals
| Return On Equity | -2.9 | ||||
| Return On Asset | -0.42 | ||||
| Operating Margin | (81.22) % | ||||
| Current Valuation | 40.79 M | ||||
| Shares Outstanding | 7.98 M | ||||
| Shares Owned By Insiders | 28.28 % | ||||
| Shares Owned By Institutions | 12.91 % | ||||
| Number Of Shares Shorted | 127.26 K | ||||
| Price To Earning | 4.09 X | ||||
| Price To Book | 7.83 X | ||||
| Price To Sales | 73.66 X | ||||
| Revenue | 654 K | ||||
| Gross Profit | 447 K | ||||
| EBITDA | (43.24 M) | ||||
| Net Income | (49.5 M) | ||||
| Cash And Equivalents | 16.23 M | ||||
| Cash Per Share | 0.22 X | ||||
| Total Debt | 32.16 M | ||||
| Current Ratio | 3.49 X | ||||
| Book Value Per Share | 2.08 X | ||||
| Cash Flow From Operations | (30.17 M) | ||||
| Short Ratio | 1.90 X | ||||
| Earnings Per Share | (5.29) X | ||||
| Target Price | 45.17 | ||||
| Number Of Employees | 82 | ||||
| Beta | 0.42 | ||||
| Market Capitalization | 32.56 M | ||||
| Total Asset | 52.34 M | ||||
| Retained Earnings | (242.72 M) | ||||
| Working Capital | 13.52 M | ||||
| Net Asset | 52.34 M |
About Clene Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Clene Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Clene using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Clene Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
When determining whether Clene Inc is a strong investment it is important to analyze Clene's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Clene's future performance. For an informed investment choice regarding Clene Stock, refer to the following important reports: Check out Clene Piotroski F Score and Clene Altman Z Score analysis. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Clene. If investors know Clene will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Clene listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Clene Inc is measured differently than its book value, which is the value of Clene that is recorded on the company's balance sheet. Investors also form their own opinion of Clene's value that differs from its market value or its book value, called intrinsic value, which is Clene's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Clene's market value can be influenced by many factors that don't directly affect Clene's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Clene's value and its price as these two are different measures arrived at by different means. Investors typically determine if Clene is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Clene's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.